BOTHELL, Wash.--(BUSINESS WIRE)--Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and chief executive officer, is scheduled to present at the 12th Annual BIO CEO & Investor Conference at 9:00 a.m. EST on Tuesday, February 9, 2010 at the Waldorf=Astoria Hotel in New York. The conference will provide a forum to discuss breakthrough therapeutic developments and issues that affect the biotech industry.
